Shanghai Fosun Pharmaceutical

Shanghai Fosun Pharmaceutical (Group) Co Ltd is a unit of one of China’s largest conglomerates Fosun International. Already listed in Shanghai, the group plans to raise about US$512 million through an initial public offering in November 2012, and said it would use about half the proceeds for domestic and international acquisitions, and the rest for research and development and to pay down debt.

Guo Guangchang, the chairman of the Fosun Group, is widely recognised as a value investor and swift decision maker. Photo: Bloomberg

The making of tycoon Guo Guangchang

When three graduates from Shanghai's prestigious Fudan University set up a small venture about two decades ago, they probably never expected the company would become an icon of the mainland's fast-growing private businesses sector.